Forbes contributors publish independent expert analyses and insights. Expert in AI for healthcare and longevity biotechnology Sep 27, 2023, 12:53pm EDT This article is more than 2 years old. The ...
Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...
I examine the applicability of relative R&D spending as a potential leading indicator of shareholder returns. In addition, the correlation of R&D spending with stock volatility and sales growth is ...
Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...
LEEDS, England--(BUSINESS WIRE)-- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome ...
LONDON (Reuters) - At just 28, Duncan Casey has already been from the university science bench to the world of Big Pharma research and back again. Now working in an Imperial College lab tucked behind ...
The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics ...
LEEDS, England--(BUSINESS WIRE)-- 4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results